Recent Publications and Grants

Engaged in diverse basic, translational and clinical research, our faculty routinely publish in prestigious journals and successfully compete for major grants from national funders.

Recent Publications

Research Grants

  • A Multicenter Randomized Controlled Trial of Best Available Therapy versus Autologous Hematopoietic Stem Cell Transplant for Treatment-Resistant Relapsing Multiple Sclerosis, BEAT-MS (Protocol ITN077AI). Bianca Weinstock-Guttman (Principal Investigator). National Institute of Allergy & Infectious Diseases (NIAID), Division of Allergy, Immunology &Transplantation (DAIT) via a subaward. 1/1/2020-12/1/2026.
  • VA Merit Review, 2IO1BX002659, Preventing and Reversing Interstitial Fibrosis in HFpEF. John Canty, Jr. (Principal Investigator). Department of Veterans Affairs. $709,984. 7/1/2020-6/1/2026.
  • The role of neutrophils in the age-driven decline in anti-pneumococcal vaccine responses. Elsa Bou Ghanem (Principal Investigator). NIA-R01. $1,575,931. 9/1/2021-5/1/2026.
  • Optimizing Chest Compressions for Bradycardia during Neonatal Resuscitation. Praveen Chandrasekharan (Principal Investigator). R01 - Eunice Kennedy Shriver National Institute of Child Health & Human Development. $1,500,000. 5/1/2021-4/1/2026.
  • Research Training on Alcohol Etiology and Treatment. Brian Quigley (Contributor). NIAAA. $2,508,143. 5/1/2021-4/1/2026.
  • Optimizing Chest Compressions Targeting Gas Exchange and Hemodynamics in a Transitional Cardiac Arrest Model. Ferdinand Schweser (Co-Investigator). National Institutes of Health. $1,642,389. 4/1/2021-3/1/2026.
  • Synaptic and Genetic Mechanisms of Sex-Specific Effects of Stress. Zhen Yan (Principal Investigator). NIH. $2,621,841. 4/1/2021-1/1/2026.
  • A 5-Year Longitudinal Observational Study of Patients Undergoing Therapy for Immune-Mediated Inflammatory Skin Conditions. Heather Lehman (Principal Investigator). TARGET PharmaSolutions, Inc. 1/1/2020-12/1/2025.
  • A Multicenter, Longitudinal, Open-Label, Single-Arm Study Describing Cognitive Processing Speed Changes in Relapsing Multiple Sclerosis Subjects Treated with Ozanimod (RPC-1063). Bianca Weinstock-Guttman (Principal Investigator). Celgene International. 6/1/2020-12/1/2025.
  • Bacterial sialometabolic activity impacts periodontal immunity and microbiota. Yijun Sun (Co-Investigator). NIH. $1,930,340. 9/1/2020-8/1/2025.
  • Effect of Complex Mixtures of Oxidative Stress and Cognition in Children. Richard Browne (Co-Investigator). NIH/NIEHS. 9/1/2020-6/1/2025.
  • Deep gray matter iron and disease progression in multiple sclerosis. Ferdinand Schweser (Principal Investigator). National Institutes of Health. $1,808,000. 7/1/2021-6/1/2025.
  • Sex related differences in Brain Gut Microbiome (BGM )Interactions in Irritable Bowel Syndrome. Jeffrey Lackner (Co-Investigator). NIH NIDDK. $7,757,028. 5/1/2020-4/1/2025.
  • Advanced computational approaches to delineating dynamic cancer progression processes by using massive static sample data. Yijun Sun (Principal Investigator). NIH. $1,964,300. 4/1/2020-3/1/2025.
  • Structural Studies of Nonribosomal Peptide Synthesis (R35GM136235). Andrew Gulick (Principal Investigator). NIH/NIGMS. 4/1/2020-3/1/2025.